These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 29793275)
21. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171 [TBL] [Abstract][Full Text] [Related]
22. How will GINA influence participation in pharmacogenomics research and clinical testing? Dressler LG; Terry SF Clin Pharmacol Ther; 2009 Nov; 86(5):472-5. PubMed ID: 19844223 [TBL] [Abstract][Full Text] [Related]
23. Ethics and policy perspectives on personalized medicine in the post-genomic era. Landon MR J Biolaw Bus; 2005; 8(3):28-36. PubMed ID: 16459425 [TBL] [Abstract][Full Text] [Related]
24. Psychiatric pharmacists' perception on the use of pharmacogenomic testing in the mental health population. Shishko I; Almeida K; Silvia RJ; Tataronis GR Pharmacogenomics; 2015; 16(9):949-58. PubMed ID: 26100610 [TBL] [Abstract][Full Text] [Related]
25. Genetic testing insurance coverage trends: a review of publicly available policies from the largest US payers. Graf MD; Needham DF; Teed N; Brown T Per Med; 2013 May; 10(3):235-243. PubMed ID: 29768740 [TBL] [Abstract][Full Text] [Related]
26. Implementation of a pharmacogenomics service in a community pharmacy. Ferreri SP; Greco AJ; Michaels NM; O'Connor SK; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer MW J Am Pharm Assoc (2003); 2014; 54(2):172-80. PubMed ID: 24632932 [TBL] [Abstract][Full Text] [Related]
27. Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine research. Kennedy MA; Joyce PR; Begg EJ Pharmacogenomics; 2012 Jun; 13(8):865-8. PubMed ID: 22676191 [TBL] [Abstract][Full Text] [Related]
28. NAVAGATE: a rubric to move from pharmacogenomics science to pharmacogenomics practice. Roederer MW Pharmacogenomics; 2012 Aug; 13(11):1307-13. PubMed ID: 22920399 [TBL] [Abstract][Full Text] [Related]
29. Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes. Altar CA; Carhart JM; Allen JD; Hall-Flavin DK; Dechairo BM; Winner JG Pharmacogenomics J; 2015 Oct; 15(5):443-51. PubMed ID: 25686762 [TBL] [Abstract][Full Text] [Related]
30. [From pharmacogenetics to pharmacogenomics: the start of a new era of personalized medicine in nephrology]. Zaza G; Granata S; Mangino M; Grandaliano G; Schena FP G Ital Nefrol; 2010; 27(4):353-66. PubMed ID: 20672232 [TBL] [Abstract][Full Text] [Related]
31. Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologies. Samwald M; Miñarro Giménez JA; Boyce RD; Freimuth RR; Adlassnig KP; Dumontier M BMC Med Inform Decis Mak; 2015 Feb; 15():12. PubMed ID: 25880555 [TBL] [Abstract][Full Text] [Related]
32. Relevance of pharmacogenomics for developing countries in Europe. Mitropoulos K; Johnson L; Vozikis A; Patrinos GP Drug Metabol Drug Interact; 2011; 26(4):143-6. PubMed ID: 22017487 [TBL] [Abstract][Full Text] [Related]
33. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice. Squassina A; Manchia M; Manolopoulos VG; Artac M; Lappa-Manakou C; Karkabouna S; Mitropoulos K; Del Zompo M; Patrinos GP Pharmacogenomics; 2010 Aug; 11(8):1149-67. PubMed ID: 20712531 [TBL] [Abstract][Full Text] [Related]
34. Pharmacogenomics: the promise of personalized medicine for CNS disorders. de Leon J Neuropsychopharmacology; 2009 Jan; 34(1):159-72. PubMed ID: 18800072 [TBL] [Abstract][Full Text] [Related]